Sinacell

Sinacell, founded in 2007 in Tehran, Iran, is a pioneering enterprise in stem cell research, tissue engineering, and regenerative medicine. We are renowned for being the first in Iran to produce advanced biological wound dressings based on human amniotic membrane, notably our flagship product, Cell-Amniosin. Certified by GMP, IMED, and ISO13485, Sinacell ensures the highest standards of quality and safety in our products. Our offerings include cell-based medical products, placental derivatives, and cutting-edge biological dressings. Additionally, we provide comprehensive cell therapy services, specializing in the manufacturing and expansion of human mesenchymal and fibroblast cells for therapeutic applications. Dedicated to innovation and excellence, Sinacell's robust R&D initiatives drive the development of new therapies and medical solutions, contributing to advancements in healthcare and improved patient outcomes.